Eli Lilly: Elanco has now closed its IPO
(CercleFinance.com) - Eli Lilly's animal health unit Elanco has closed its initial public offering (IPO), raising approximately 1.
7 billion dollars, the company said on Monday.
Elanco said it has issued 62.9 million ordinary shares at a price of 24 dollars per share for the public.
Relative to the IPO, underwriters have fully exercised their option to purchase an additional 9.4 million shares, bringing the total to 72.3 million shares.
The shares began trading on the New York Stock Exchange on 20 September. They risen by over 45% since then.
At the closing of the IPO, Lilly held approximately 80.2% of Elanco, which it plans to divest.
The net proceeds from the IPO have been paid to Lilly.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
7 billion dollars, the company said on Monday.
Elanco said it has issued 62.9 million ordinary shares at a price of 24 dollars per share for the public.
Relative to the IPO, underwriters have fully exercised their option to purchase an additional 9.4 million shares, bringing the total to 72.3 million shares.
The shares began trading on the New York Stock Exchange on 20 September. They risen by over 45% since then.
At the closing of the IPO, Lilly held approximately 80.2% of Elanco, which it plans to divest.
The net proceeds from the IPO have been paid to Lilly.
Copyright (c) 2018 CercleFinance.com. All rights reserved.